Cargando…
Counterfeit Drug Penetration into Global Legitimate Medicine Supply Chains: A Global Assessment
Counterfeit medicines are a global public health risk. We assess counterfeit reports involving the legitimate supply chain using 2009–2011 data from the Pharmaceutical Security Institute Counterfeit Incident System (PSI CIS) database that uses both open and nonpublic data sources. Of the 1,510 ident...
Autores principales: | Mackey, Tim K., Liang, Bryan A., York, Peter, Kubic, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455087/ https://www.ncbi.nlm.nih.gov/pubmed/25897059 http://dx.doi.org/10.4269/ajtmh.14-0389 |
Ejemplares similares
-
An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain
por: Cuomo, Raphael E, et al.
Publicado: (2014) -
Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism
por: Mackey, Tim K, et al.
Publicado: (2013) -
The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring
por: Jarrett, Stephen, et al.
Publicado: (2020) -
Global use of asbestos - legitimate and illegitimate issues
por: Frank, Arthur L.
Publicado: (2020) -
Monitoring the Quality of Medicines: Results from Africa, Asia, and South America
por: Hajjou, Mustapha, et al.
Publicado: (2015)